Revolutionizing the Future of Healthcare: How to Make Precision Medicine a Reality | Gabriele Allegri

Precision medicine stands to redefine healthcare by tailoring treatments to each patient’s unique genetic and environmental profile. Gabriele Allegri, VP of Global Commercial Precision Medicine at Johnson & Johnson, outlines a strategic framework to overcome key barriers to its widespread adoption. His roadmap emphasizes building clinical evidence, integrating fragmented data, creating innovative reimbursement models, and fostering public-private partnerships. Allegri stresses the need for equitable access and patient trust to ensure that socioeconomic factors do not limit access to life-saving treatments. With a collective effort, precision medicine could become the global standard, shifting healthcare from generalized care to truly personalized treatment.